Apply for funds

Apply
for funding

APPLICATIONS FOR OUR CALL FOR PROPOSALS 2024 ARE NOW CLOSED.

The latest data from the World Health Organization’s (WHO) Global Hepatitis Report 2024 show that viral hepatitis remains a major public health challenge, with the world still far from eliminating it by 2030. Hepatitis B and C continue to cause significant mortality, claiming over 1.3 million lives each year due to complications like liver disease and cancer. In 2022, viral hepatitis and tuberculosis were the second leading causes of death among communicable diseases following COVID-19.

Globally, an estimated 254 million people are living with hepatitis B, 50 million with hepatitis C, and 6,000 people are newly infected with viral hepatitis each day. In most countries, many people remain undiagnosed, and even when hepatitis is diagnosed, the number of people receiving treatment remains incredibly low.

Despite the availability of affordable medicines, many countries are not fully utilising these treatments due to policy, programmatic, and access barriers. Similarly, many infants do not receive the hepatitis B birth-dose vaccination along with at least two additional recommended doses despite the low cost of this intervention. Funding for viral hepatitis remains limited.

Urgent and coordinated action is needed to overcome these obstacles and get the global response back on track. This includes increasing funding, improving diagnosis rates, expanding treatment accessibility, and addressing systemic barriers. It is crucial to maximise the use of available tools and ensure fair access to interventions to effectively end the hepatitis epidemics.

Hepatitis elimination

Call for proposals 2024

"Transformative programmes to advance hepatitis elimination"

The Hepatitis Fund is launching a second round of proposals on 29 July 2024 for the period 2025-2027.

Through this multi-year funding opportunity, organisations may apply for grants to support their work to eliminate viral hepatitis as a public health threat.

Grants will be allocated to projects serving hepatitis B and C populations in low- and middle-income countries in Asia and Africa.

 

THF will consider proposals for projects divided into two tracks:

Track 1: Will focus on the advancement of planning and financing elimination activities, particularly through the provision of technical assistance to support national government leaders.

Track 2: Will focus on the development or delivery of programme services by the implementing organisation.

PLEASE NOTE THAT SUBMISSIONS FOR THIS CALL CLOSED ON 10 SEPTEMBER 2024.

Funding tracks

  • Harnessing the power of data to engage senior leaders and make the data easy to understand for key stakeholders so that they are moved to confront the burden of hepatitis. For example, there are untapped databases which provide data, modelling tools, and decision analytics to support eliminating hepatitis B and C globally by 2030.
  • Working with Ministry of Health and Ministry of Finance officials to develop strategic financing approaches. While most countries with a significant burden/prevalence of viral hepatitis have national action plans to address the disease, they are often limited in scope, ambition and implementation to reach elimination goals due to the perceived insurmountable costs.
Example of activities include, but are not limited to:
  • Costing a viral hepatitis elimination plan
  • Making the investment case for hepatitis elimination
  • Examining innovative financing mechanisms to meet those costs.
  • Showcasing the outcomes of financing strategies to demonstrate to other countries what is possible.
  • Establishing quality national data collection, surveillance, and modelling
  • Building capacity for monitoring and evaluating the hepatitis programme indicators
  • Providing technical expertise to key decision makers in governments to advance their top priorities to test and treat viral hepatitis.

I. Saving lives by promoting maternal, newborn, and child health.  

Vertical transmission (also known as mother-to-child-transmission, or MTCT) is the most common form of transmission of hepatitis B (HBV) in many high-prevalence areas such as East Asia and Africa and may occur in up to 90% of infants of mothers with chronic HBV, if specific ante- and perinatal interventions are not provided.

Birthing facilities are an underutilised channel for delivering comprehensive services for the prevention of HBV infection in children, particularly HBV birth-dose vaccination. Integrating prevention of vertical transmission of HBV (PMTCT) into routine perinatal care promotes maternal, newborn and child health and strengthens health care delivery systems in general.

Illustrative activities include, but are not limited to:

  • Increasing facility-based delivery
  • Expanding and rolling out timely birth dose vaccination
  • Increase uptake, availability, and quality of HBV PMTCT services among pregnant women
  • Assess and develop strategies to address HBV PMTCT service implementation.


II. Accelerating access to testing and treatment approaches 

Implementing efficient and innovative approaches for accelerating the testing of populations for hepatitis to identify those persons who have chronic infection and link them to appropriate care.

Illustrative activities include, but are not limited to:

  • Decentralising hepatitis services and task shifting of hepatitis care.
  • Raising awareness about the viral hepatitis challenge and solutions
  • Supporting advocacy and technical assistance for increased financing at global and national level
  • Integrating people centred hepatitis services delivery within universal health coverage
  • Ensuring equitable access to essential medicines and technologies to address viral hepatitis by improving procurement systems
  • Screening key populations and addressing stigma associated with viral hepatitis infections
  • Integrating hepatitis care into other relevant health programmes
  • Increase general health workforce competencies relating to viral hepatitis testing and treatment
  • Developing and use of e-health tools, cost-effective and secure communication technologies as a key enabler in the delivery in the health care services.
  • Increasing awareness and communicating patient education, e.g., by engaging civil  society and patient support groups
  • Sharing best practices and lessons learned to facilitate scaled-up roll-out across countries

For Track 1 and 2

THF encourages and priorities e-health initiatives that enhance and promote health data sharing and evidence-based and innovative approaches to facilitate access to testing and linking to care and treatment.

For Track 2

On Service Delivery programmes, THF encourages ALL projects to include and integrate the local community, local government and activities to raise awareness and demand. Advocacy efforts should be specifically tailored and integrated into the service delivery programmes to increase awareness and garner political backing.

Criteria

Funding eligibility criteria

Before you apply, please make sure your proposal is aligned with the eligibility outlined criteria.

Is the primary purpose of the work to advance the efforts to eliminate viral hepatitis?

The Hepatitis Fund funds proposals that are focused on viral hepatitis elimination. 

THF’s grant-making strategy focuses on three areas, guided by the WHO Global Health Sector Strategies: HIV, viral hepatitis, and sexually transmitted infections for 2022-2030.

a. Accelerating planning and implementation of national elimination strategies by:

  • Decentralising hepatitis services and task shifting of hepatitis care
  • Raising awareness about the viral hepatitis challenge and solutions
  • Supporting advocacy and technical assistance for increased financing at global and national levels.

b. Integrating people-centred hepatitis services delivery within Universal Health Coverage, with a specific focus on:

  • Ending vertical transmission of hepatitis B via antenatal screening and antiretroviral treatment
  • Rolling out of hepatitis B virus birth-dose vaccine in every national immunisation schedule
  • Preventing all new viral hepatitis B and C infections among children and address the treatment and care needs of affected children and adolescents.
  • Ensuring equitable access to essential medicines and technologies to address hepatitis B, C and D viruses, including by improving procurement systems
  • Screening key populations and addressing stigma associated with viral hepatitis infections
  • Integrating hepatitis care into other relevant health programmes.
  • Improving and integrating data systems for better policy formulation, surveillance, and modelling.

c. Strengthening national health systems capacity, for example by:

  • Deliver high-quality, evidence-based people-centred services. This should be aligned with universal health coverage benefit coverage
  • Increase general health workforce competencies relating to viral hepatitis testing and treatment
  • Developing and using e-health tools and cost-effective and secure communication technologies as a key enabler in healthcare services
  • Providing technical expertise to key government decision-makers to advance their priorities in testing and treating viral hepatitis.

THF supports proposals that use innovative approaches to accelerate hepatitis elimination efforts. To be successful, proposed ideas should integrate one or a combination of scientific/technological, socio-cultural, and/or multi-sectoral innovations. 

THF funds proposals that can sustain themselves after financial support from the grant ends. Proposals should also provide a path and have the potential for impact at scale. Examples may include the involvement of partners who can help the innovation scale, the potential to leverage or generate funding to sustain the innovation, and alignment with other relevant health priorities and plans. 

THF supports proposals focusing on Africa or Asia since the disproportionate burden of viral hepatitis in these regions. 

The Hepatitis Fund supports projects that are “lean” in their design, and require the minimum financial support required to achieve the desired outcome.

THF funds programmes delivered by implementing organisations. Applicants should have a successful track record in implementing similar projects and be able to demonstrate their ability and capacity to provide the proposed project and their ability to support the elimination of viral hepatitis.   

Catalytic funding is grant-making that aims for sustained impact beyond agreed deliverables. Projects funded by THF are designed to demonstrate interventions that accelerate hepatitis elimination, with the intention of national and regional domestic health systems adopting them.

We support projects that work within the Sustainable Development Goals and Universal Health Coverage (UHC) framework – creating incentives for governments to include hepatitis elimination in their UHC programme and integrate hepatitis with primary care, sexual and reproductive health, perinatal and immunization services.

Process timeline

Documents

Additional information and document templates

More information about the call is available in the following documents:

Applications for this call are now closed. If you have any questions or queries regarding the selection process, please contact:
grants@thehepatitisfund.org or browse our FAQs document.